Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by CBS News cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article indicated that Teva, the largest US supplier of amphetamine/dextroamphetamine (Adderall), expects shortages of the drug to persist for the next 2 to 3 months.
Becker’s Hospital Review featured an article discussing the findings of a study published in the September 2022 issue of AJMC®. The study, “Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use Disorder,” found that most physicians want to continue using telehealth to treat opioid use disorder after the pandemic ends. The results were also highlighted by the Yale School of Medicine.
News24 cited a video interview published on AJMC.com. The video interview with Rona Z. Silkiss, MD, FACS, an oculoplastic surgeon and owner of Silkiss Eye Surgery, reviewed the use of biologics to treat thyroid eye disease.
Expert Insights on How Utilization Management Drives Physician Burnout
November 26th 2024On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.
Listen
NCCN Guidelines Prioritize Quad Therapy in Multiple Myeloma
November 26th 2024In the most recent update to the National Comprehensive Cancer Network (NCCN) guidelines for treating patients who have multiple myeloma, a quadruplet regimen became the preferred first-line treatment option for transplant-eligible and -ineligible patients.
Read More
Metformin Improves Symptoms and Gene Expression in Central Centrifugal Cicatricial Alopecia
November 26th 2024Patients with treatment-resistant central centrifugal cicatricial alopecia saw improvement in symptoms and gene expression, suggesting the potential of metformin as a new treatment option.
Read More